Abstract
Thiazide diuretics are reported to have antioxidant effects and reduce pulse pressure (PP). The aim of this study was to elucidate whether hydrochlorothiazide additionally exerts such effects in stroke patients under treatment with losartan. This study was an open-label, randomized, multicenter study. Patients with a history of chronic stroke and treatment with angiotensin receptor blockers or angiotensin-converting enzyme inhibitors for essential hypertension were enrolled. Fifty-five hypertensive patients were randomly assigned to two groups: those further treated with hydrochlorothiazide and those further treated with non-diuretic antihypertensive drugs. Both groups showed a significant decrease in PP over six months (hydrochlorothiazide group: 67±12 mmHg to 58±12, p<0.001; non-diuretic group: 72±12 to 61±12, p<0.001), although no significant differences were observed between the two groups. The malondialdehyde-modified low-density lipoprotein levels did not change significantly after treatment in either group. In this study, hydrochlorothiazide treatment did not provide any additional benefits over non-diuretic antihypertensive drugs in terms of antioxidant effects or reducing PP.
References
Jun 26, 1991·JAMA : the Journal of the American Medical Association
Jan 1, 1989·Journal of Cardiovascular Pharmacology·H JansenJ C Birkenhäger
Sep 30, 1994·Biochemical and Biophysical Research Communications·E LupoW Vetter
Apr 1, 1996·Journal of Cardiovascular Pharmacology·E MaggiG Bellomo
Mar 1, 1997·Journal of Vascular Research·M E SafarH A Struijker-Boudier
Oct 20, 2001·Hypertension·R G AsmarUNKNOWN REASON Project Coordinators and Investigators
Oct 20, 2001·Hypertension·W C CushmanD J Reda
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
Jun 23, 2004·Lancet·Stevo JuliusUNKNOWN VALUE trial group
Feb 11, 2005·Clinical and Experimental Hypertension : CHE·Jacques de ChamplainLingyun Wu
Aug 10, 2006·Clinical and Experimental Pharmacology & Physiology·Kornelia Kedziora-KornatowskaJózef Kedziora
Jan 11, 2007·Journal of Hypertension·Koichi MiyagawaYasuaki Dohi
Sep 1, 2007·Journal of Hypertension·Giuseppe ManciaUNKNOWN ESH-ESC Task Force on the Management of Arterial Hypertension
Jan 4, 2008·Hypertension·Toshio OgiharaUNKNOWN Candesartan Antihypertensive Survival Evaluation in Japan Trial Group
Mar 21, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Toshio OgiharaUNKNOWN Japanese Society of Hypertension Committee
Dec 4, 2010·Arzneimittel-Forschung·Koichi SatoShigenori Ito
Aug 5, 2011·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Aoi KamuraKoichi Node
Sep 21, 2011·The Journal of Physiology·Vincent PialouxMarc J Poulin
Dec 1, 2011·Clinical and Experimental Nephrology·Tatsuo HosoyaT Yoshizawa
Mar 22, 2012·Cerebrovascular Diseases·Hiroaki SauraAkira Ogawa
Apr 27, 2012·Clinical and Experimental Hypertension : CHE·Toshihiro KitaKazuo Kitamura
Citations
Aug 31, 2016·Molecular Medicine Reports·Zhiyou CaiGuanghui Chen
Dec 18, 2019·The Korean Journal of Internal Medicine·Eunjung ParkMihn-Sook Jue
Nov 1, 2020·International Journal of Environmental Research and Public Health·Onchuma MueangsonWarangkana Chunglok